Anna Pratsinis

Roche (Switzerland)

Papers

1

Total Citations

32

H-Index

1

About

Anna Pratsinis is a rising leader in the field of lipid nanoparticle engineering, with a focused expertise in the structural optimization of drug delivery systems. Her research centers on the critical interplay between lipid composition and manufacturing processes, specifically investigating how non-ionizable lipids and phase mixing methods influence the physical and chemical properties of lipid nanoparticle (LNP) formulations. Pratsinis’s most-cited work, “Impact of non-ionizable lipids and phase mixing methods on structural properties of lipid nanoparticle formulations” (2023, 32 citations), provides foundational insights into designing more stable and effective LNPs for nucleic acid and small molecule delivery. By systematically characterizing how formulation parameters govern particle size, encapsulation efficiency, and colloidal stability, her contributions directly advance the rational design of next-generation nanocarriers. This work is particularly impactful for improving the performance of mRNA vaccines and gene therapies. As a researcher whose early-career output is already shaping best practices in nanomedicine, Pratsinis is establishing herself as a key voice in the transition from empirical formulation to predictive, structure-based LNP design.

Research Focus

Key Achievements

1
H-Index
1
Papers
32
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
Impact of non-ionizable lipids and phase mixing methods on structural properties of lipid nanoparticle formulations
32 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Roche (Switzerland)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago